Bullfrog Ai Holdings Inc (BFRG) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Bullfrog Ai Holdings Inc   (NASDAQ: BFRG)

Bullfrog Ai Holdings Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Bullfrog Ai Holdings Inc in the second quarter 2026?
Bullfrog Ai Holdings Inc recorded a cumulative net loss of $-6 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -150.34%.

Within the Major Pharmaceutical Preparations industry 281 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 3604 to 3683.

What is ROE?




Return On Equity (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Equity Change 219.33 % 50.53 % -56.96 % -49.16 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -6 -6 -6 -7 -7
Return On Equity (TTM) -150.34 % -217.79 % -273.18 % -218.2 % -195.32 %
BFRG's Total Ranking # 3683 # 3604 # 3380 # 3351 # 3168
Equity (TTM) in Millions 7 5 2 2 2
Seq. Equity Change 42.98 % 128.75 % 9.91 % -11.17 % -32.6 %
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry # 282
Sector # 610
Overall # 3683

Return On Equity Statistics
High Average Low
-130.79 %
-171.8 %
-273.18 %
(Jun 30 2024)   (Dec 31 2025)



  News about Bullfrog Ai Holdings Inc Return on Equity ROE

Navigating Challenges: BullFrog AIs Strategic Vision for Growth Amidst Financial Hurdles,

GAITHERSBURG, Md. Dec. 27, 2024 – BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a pioneering technology-enabled drug development company that leverages artificial intelligence (AI) and machine learning to enhance the development of pharmaceuticals and biologics, recently communicated with its stockholders through a letter issued by CEO Vin Singh. The letter outlines the company s current position, its financial performance over the year, and future strategies as it continues to face significant challenges in the competitive landscape of drug development.Financial Performance and Market ChallengesAs of the date of the letter, BullFrog AI s stock has experienced a troubling -30.33% decline year-to-date, a figure that may concern both current and prospective investors. This decline has occurred in the context of a challenging operating environment, marked by a cumulative net loss of $6 million over the twelve months ending in the first quarter of 2024. This financial performance has resulted in a disquieting negative return on equity (ROE) of -131.39%, a metric that highlights the ongoing struggles the company faces to convert investments into profit.




BFRG Annual Return On Equity (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022

Total Equity in Millions 2 5 3 -3 0
Y / Y Equity Change -56.96 % 91.48 % - - -
Net Income in Millions -6 -7 -5 -3 0
Y / Y Net Income Change - - - - -
Return On Equity -304.17 % -140.89 % -206.61 % - -





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BFRG's' Return on Equity at Yahoo Finance
BFRG's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BFRG's Competitors
Subscribers only: Roe for Bullfrog Ai Holdings Inc 's Suppliers
Subscribers only: Return On Equity for BFRG's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE


Date modified: 2026-09-26T07:42:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.